Invuity Announces Pricing of Public Offering of Common Stock
16 March 2018 - 12:47AM
Invuity, Inc. (NASDAQ:IVTY) (“Invuity” or the “Company”), a leading
medical technology company focused on minimal access surgery, today
announced the pricing of its public offering of 6,200,000 shares of
its common stock at a price to the public of $3.50 per share. In
addition, the Company has granted the underwriters a 30-day option
to purchase up to 600,000 additional shares of its common stock.
William Blair & Company, L.L.C. is acting as the sole
book-running manager for the offering.
The offering is being made pursuant to an effective shelf
registration statement on Form S-3 (No. 333-212395) that was
initially filed with the U.S. Securities and Exchange Commission
(the “SEC”) on July 1, 2016. A preliminary prospectus supplement
describing the terms of the offering has been filed with the SEC
and forms a part of the effective registration statement. Copies of
the preliminary prospectus supplement and the accompanying
prospectus relating to the offering, and when available, copies of
the final prospectus supplement and the accompanying prospectus
relating to the offering may be obtained from the offices of
William Blair & Company, L.L.C., Attention: Prospectus
Department, 150 North Riverside Plaza, Chicago, IL 60606;
Telephone: (800) 621-0687 or by email at
prospectus@williamblair.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on
developing and marketing advanced surgical devices to improve the
ability of physicians to perform minimal access surgery through
smaller and hidden incisions. The Company’s patented Intelligent
Photonics® technology delivers enhanced visualization, which
facilitates surgical precision, efficiency and safety.
Clinical applications include women’s health, encompassing
breast cancer and breast reconstruction surgery, gynecology and
thyroid surgery. Additional applications include procedures
for electrophysiology, spine, orthopedic, cardiothoracic and
general surgery. Invuity is headquartered in San Francisco, CA.
Forward-Looking Statements
This announcement contains forward-looking statements within the
meaning of the Securities Act of 1933, as amended, the Securities
Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995. These forward-looking statements,
including statements regarding the public offering, are subject to
a number of risks and uncertainties which may cause actual results
or outcomes to be materially different from those expressed or
implied by the forward-looking statements. These risks and
uncertainties include market risks and uncertainties and risks and
uncertainties relating to the satisfaction of customary closing
conditions for an underwritten offering of securities, as well as
the risks and uncertainties that could affect the Company’s
business and financial results described in the preliminary
prospectus supplement, final prospectus supplement and registration
statement referenced above, as well as the Company’s other filings
with the SEC, including, without limitation, under the caption
“Risk Factors.” There can be no assurance that the Company will be
able to complete the public offering on the anticipated terms, or
at all. Forward-looking statements relate only to events as of the
date on which the statements are made, and the Company undertakes
no obligation to publicly update or review any forward-looking
statement.
CONTACT:
Company Contact: Jim Mackaness Chief Financial Officer Invuity,
Inc. 415-655-2129
Investors: Mark Klausner Westwicke Partners 443-213-0501
irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Apr 2024 to May 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From May 2023 to May 2024